Loxo Oncology Vs. Ignyta: The Grudge Match

Seeking Alpha-28 minutes ago

I have been watching the Loxo Oncology (LOXO) vs. Ignyta (NASDAQ:RXDX) battle for quite a long period of time. It is fascinating that two companies that are ...

Chicago Radiological Society gives highest honor to Loyola ...

EurekAlert (press release)-42 minutes ago

Loyola Medicine radiation oncologist Edward Melian, MD, has received the Chicago Radiological Society's 2017 Distinguished Service Award, the highest ...

Aptevo Therapeutics Presents Detailed Overview of its Adaptir ...

GlobeNewswire (press release)-43 minutes ago

Aptevo Therapeutics Inc. is a biotechnology company focused on novel oncology and hematology therapeutics to meaningfully improve patients' lives. Our core ...

Sports Perspectives

Cancer Genetics to Hold First Quarter 2017 Earnings Call on Friday ...

GlobeNewswire (press release)-57 minutes ago

RUTHERFORD, N.J., May 05, 2017 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) a leader in enabling precision medicine for oncology through ...

Analyst Research and Ratings: AbbVie Inc. (ABBV), Clovis Oncology ...

W News-1 hour ago

AbbVie Inc. (NYSE:ABBV) tinted gains of +0.73% (+0.49 points) to US$67.23. The volume of 4.27 Million shares climbed down over an trading activity of 6.04 ...

Markets Daily

Clovis Oncology (CLVS) Earning Somewhat Favorable Press ...

Sports Perspectives-1 hour ago

Clovis Oncology logo Press coverage about Clovis Oncology (NASDAQ:CLVS) has been trending somewhat positive this week, Alpha One Sentiment Analysis ...

Keytruda Crosses First-Line Finish Line First

Managed Care magazine-1 hour ago

Now oncologists will have to test for PD-L1, in addition to EGFR and ALK aberrations, and the National Comprehensive Cancer Network has added routine ...

DailyNewsKs

Hypopharyngeal Cancer Pipeline Review, H1 2017 Market Analysis ...

satPRnews (press release)-2 hours ago

The pipeline guide reviews pipeline therapeutics for Hypopharyngeal Cancer (Oncology) by companies and universities/research institutes based on ...

DailyNewsKs

New Market Therapeutics Development On Cancer Anorexia ...

satPRnews (press release)-2 hours ago

The pipeline guide reviews pipeline therapeutics for Cancer Anorexia-Cachexia Syndrome (Oncology) by companies and universities/research institutes based ...

The Newburgh Press

Clovis Oncology, Inc.'s (CLVS) noted a price change of -3.64% and ...

Stocks Gallery-2 hours ago

Clovis Oncology, Inc. (CLVS) stock moved with shift of -11.77% in the past week. During the last month, the stock has changed -16.01% and performed 80.02% ...